ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672045 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672045; 2) Community: the network communities that were significantly associated with the response to NSC 672045; 3) Molecule: the relationships between components within communities and NSC 672045; 4) MDR: the compounds that were significantly associated with the NSC 672045.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0430505868034761 0.21663291
NSC 72961 8-Azadenosine 0.0430505868034761 0.32272461
NSC 732178 Null 0.0430505868034761 0.24824918
NSC 735030 Null 0.0430505868034761 0.39225405
NSC 736802 Null 0.0430505868034761 0.32233171
NSC 743528 Null 0.0430505868034761 0.32076327
NSC 743530 Null 0.0430505868034761 0.3368467
NSC 746540 Null 0.0430505868034761 0.4419492
NSC 758881 Orlistat (USAN) 0.0430505868034761 0.21556004
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0430505868034761 0.072322425
Total:132  Current:115    [First] [Prev] [Next] [Last]